Vanta Bioscience Limited (BOM:540729)

Market Cap	175.41M
Revenue (ttm)	45.88M
Net Income (ttm)	-38.48M
Shares Out	6.31M
EPS (ttm)	-6.10
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	750
Average Volume	2,963
Open	27.79
Previous Close	27.29
Day's Range	27.79 - 27.79
52-Week Range	19.08 - 64.84
Beta	0.80
RSI	67.38
Earnings Date	Jul 18, 2025

About Vanta Bioscience

Vanta Bioscience Limited, together with its subsidiaries, operates as a preclinical contract research organization in India. It offers a range of services in method development, validation, impurity profiling, impurity isolation, characterization, certification and evaluation, mammalian and genetic toxicology, drug metabolism, pharmacokinetics, and bio-analysis during the preclinical stage of drug development. The company also provides testing services for agrochemicals and chemicals, such as physico-chemical testing; sub-acute, sub-chronic, an...

• Industry: Commercial Physical and Biological Research
• Founded: 2016
• Employees: 48
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 540729

Financial Performance

In 2023, Vanta Bioscience's revenue was 97.23 million, an increase of 54.92% compared to the previous year's 62.76 million. Losses were -23.16 million, -64.26% less than in 2022.